Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
Uwe ReuterPeter J GoadsbyMichel D FerrariGabriel Paiva Da Silva LimaSubhayan MondalJawed KalimFatima HasanShihua WenMichal ArkuszewskiShaloo PandhiTracy StitesMichel Lanteri-MinetPublished in: Neurology (2024)
ClinicalTrials.gov Identifier: NCT03096834.
Keyphrases